Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
about
Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data.Management of Hypertension Using Olmesartan Alone or in CombinationEffectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice.Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results.Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goalsWhat is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?Leg edema with (S)-amlodipine vs conventional amlodipine given in triple therapy for hypertension: a randomized double blind controlled clinical trial.A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval.Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups.Twenty-four-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation.Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.Calcium channel blockers in cardiovascular pharmacotherapy.Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome
P2860
Q31123979-C849BE8B-D867-429B-B60B-4B7E4C7412EDQ33734043-AC68A88B-AD4E-419C-A5CC-2CA7C39EAF47Q34139114-FEC727C6-7656-4F1F-AA11-89021E4F47BCQ34342123-22B247E8-E63E-444D-A5F0-2C5047E6243BQ34488929-4552E631-7908-4D2D-9453-90BBF782CB3EQ35085669-2A7C492A-BF2D-46D7-99AC-7DA40509062DQ35210540-6B592234-30E2-4F8D-AE60-CA34CA6E101AQ35959046-930FBDFE-9BC2-4BE9-B6C5-70D70C4EF080Q36120769-EF7C3DDF-C509-478A-9525-17D3D9E0A8F2Q37337313-3F12DA1F-B763-4641-8246-8E2127C76DDEQ37560384-02354753-E883-49B2-A536-16E2389D7C13Q37833661-4263E558-A943-4112-8234-F793235254DFQ37973403-E7BFA86F-8FA0-4175-94E0-D0EE8CDA70A0Q37973584-05449C94-4271-40CA-92C3-EFB11BBF8D6FQ38011638-47E6C98E-4002-4027-A0B0-235BFB11609BQ38156340-8144D093-7393-40DC-B29A-CBFD601C0008Q38215726-6A982FDE-2096-40C1-A370-5E10176E4AD6Q38465638-83480C03-CBFB-45E6-8A3C-D77CE7DA6288Q48131950-E58D9AC5-C2A9-401A-9553-87EDEAD6BECCQ57490130-2315C81C-F11F-4D46-BE24-6072BC07F8A2
P2860
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@ast
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@en
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@nl
type
label
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@ast
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@en
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@nl
prefLabel
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@ast
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@en
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@nl
P2093
P2860
P356
P1476
Efficacy and tolerability of a ...... ifficult-to-treat hypertension
@en
P2093
P2860
P2888
P304
P356
10.1038/JHH.2010.5
P577
2010-02-18T00:00:00Z
P5875
P6179
1011575253